HArry wilcox

Chairman, COO Flagship Pioneering

As COO and general partner at Flagship Pioneering, Harry is responsible for the operational management of Flagship, serves as a member of Flagship’s investment committee, and oversees the firm’s operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson and of Seahorse BioScience prior to its successful sale to Agilent Technologies. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Celexion, Seventh Sense Biosystems, T2 Biosystems (NASDAQ:TTOO), Quantum Designs, Inc (Chairman), Selventa, Inc., MidoriUSA (Acting CEO), HN Company, Inc. (Chairman and acting CEO), BG Medicine, Inc. and Be Power Tech.


Brian Baynes, Ph.D.

Director and Founder

Brian is a founder of Midori and co-inventor of its core technology. He is a Partner at Flagship Ventures, which he joined in 2004, and is a serial entrepreneur with a passion for creating new ventures at the intersection of innovative science and problems of global scale. Previously, he co-founded bioengineering companies Celexion and Codon Devices, and worked closely with portfolio companies Adnexus, BG Medicine, and Epitome Biosystems. He also worked as an engineer at Mobil and ExxonMobil, and was a Lecturer in the MIT School of Chemical Engineering Practice at Mitsubishi Chemicals and General Mills. Brian holds a BChE from the University of Delaware, and received his PhD in chemical engineering from MIT, both in chemical engineering.


Jerry A. Vergeer

Director, President JAV Inc.



David Blakemore

Director, President Animal Nutrition & Health, Royal DSM


Michael wahl

Director, Vice President Mergers & Acquisitions, Royal DSM